Mass spectrometry in Parkinson's disease.
Niwa
T
T
Department of Clinical Laboratory, Nagoya University Branch Hospital, Japan.
D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine / Q000032:analysis / Q000378:metabolism; D000818:Animals; D001921:Brain / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D007546:Isoquinolines / Q000032:analysis / Q000737:chemistry / Q000378:metabolism; D007980:Levodopa / Q000378:metabolism / Q000494:pharmacology; D013058:Mass Spectrometry / Q000379:methods; D015394:Molecular Structure; D010300:Parkinson Disease / Q000378:metabolism*; D044005:Tetrahydroisoquinolines; D014443:Tyrosine / Q000031:analogs & derivatives / Q000378:metabolism
D002395:Catecholamines; D007546:Isoquinolines; D044005:Tetrahydroisoquinolines; D014443:Tyrosine; D007980:Levodopa; C014843:1,2,3,4-tetrahydroisoquinoline; D015632:1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine